vs

Side-by-side financial comparison of INSTEEL INDUSTRIES INC (IIIN) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $159.9M, roughly 1.3× INSTEEL INDUSTRIES INC). INSTEEL INDUSTRIES INC runs the higher net margin — 4.7% vs 2.7%, a 2.1% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 23.3%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-2.2M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 12.0%).

Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

IIIN vs IRTC — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.3× larger
IRTC
$208.9M
$159.9M
IIIN
Growing faster (revenue YoY)
IRTC
IRTC
+3.8% gap
IRTC
27.1%
23.3%
IIIN
Higher net margin
IIIN
IIIN
2.1% more per $
IIIN
4.7%
2.7%
IRTC
More free cash flow
IRTC
IRTC
$16.7M more FCF
IRTC
$14.5M
$-2.2M
IIIN
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
12.0%
IIIN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IIIN
IIIN
IRTC
IRTC
Revenue
$159.9M
$208.9M
Net Profit
$7.6M
$5.6M
Gross Margin
11.3%
70.9%
Operating Margin
6.0%
1.1%
Net Margin
4.7%
2.7%
Revenue YoY
23.3%
27.1%
Net Profit YoY
602.4%
518.5%
EPS (diluted)
$0.39
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIIN
IIIN
IRTC
IRTC
Q4 25
$159.9M
$208.9M
Q3 25
$177.4M
$192.9M
Q2 25
$179.9M
$186.7M
Q1 25
$160.7M
$158.7M
Q4 24
$129.7M
$164.3M
Q3 24
$134.3M
$147.5M
Q2 24
$145.8M
$148.0M
Q1 24
$127.4M
$131.9M
Net Profit
IIIN
IIIN
IRTC
IRTC
Q4 25
$7.6M
$5.6M
Q3 25
$14.6M
$-5.2M
Q2 25
$15.2M
$-14.2M
Q1 25
$10.2M
$-30.7M
Q4 24
$1.1M
$-1.3M
Q3 24
$4.7M
$-46.2M
Q2 24
$6.6M
$-20.1M
Q1 24
$6.9M
$-45.7M
Gross Margin
IIIN
IIIN
IRTC
IRTC
Q4 25
11.3%
70.9%
Q3 25
16.1%
71.1%
Q2 25
17.1%
71.2%
Q1 25
15.3%
68.8%
Q4 24
7.3%
70.0%
Q3 24
9.1%
68.8%
Q2 24
10.6%
69.9%
Q1 24
12.3%
66.3%
Operating Margin
IIIN
IIIN
IRTC
IRTC
Q4 25
6.0%
1.1%
Q3 25
10.8%
-4.4%
Q2 25
11.0%
-10.0%
Q1 25
8.3%
-20.5%
Q4 24
1.1%
-2.5%
Q3 24
4.5%
-34.1%
Q2 24
6.0%
-15.5%
Q1 24
7.0%
-28.9%
Net Margin
IIIN
IIIN
IRTC
IRTC
Q4 25
4.7%
2.7%
Q3 25
8.2%
-2.7%
Q2 25
8.4%
-7.6%
Q1 25
6.4%
-19.3%
Q4 24
0.8%
-0.8%
Q3 24
3.5%
-31.3%
Q2 24
4.5%
-13.6%
Q1 24
5.4%
-34.6%
EPS (diluted)
IIIN
IIIN
IRTC
IRTC
Q4 25
$0.39
$0.18
Q3 25
$0.74
$-0.16
Q2 25
$0.78
$-0.44
Q1 25
$0.52
$-0.97
Q4 24
$0.06
$-0.03
Q3 24
$0.24
$-1.48
Q2 24
$0.34
$-0.65
Q1 24
$0.35
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIIN
IIIN
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$15.6M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$358.8M
$152.7M
Total Assets
$456.1M
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIIN
IIIN
IRTC
IRTC
Q4 25
$15.6M
$583.8M
Q3 25
$38.6M
$565.2M
Q2 25
$53.7M
$545.5M
Q1 25
$28.4M
$520.6M
Q4 24
$36.0M
$535.6M
Q3 24
$111.5M
$522.0M
Q2 24
$97.7M
$561.5M
Q1 24
$83.9M
$569.1M
Stockholders' Equity
IIIN
IIIN
IRTC
IRTC
Q4 25
$358.8M
$152.7M
Q3 25
$371.5M
$121.9M
Q2 25
$356.2M
$103.7M
Q1 25
$341.4M
$86.7M
Q4 24
$331.6M
$90.9M
Q3 24
$350.9M
$71.8M
Q2 24
$346.0M
$99.2M
Q1 24
$340.6M
$90.3M
Total Assets
IIIN
IIIN
IRTC
IRTC
Q4 25
$456.1M
$1.0B
Q3 25
$462.6M
$995.2M
Q2 25
$471.9M
$964.0M
Q1 25
$421.9M
$926.1M
Q4 24
$404.7M
$931.4M
Q3 24
$422.6M
$909.7M
Q2 24
$414.6M
$919.2M
Q1 24
$397.2M
$909.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIIN
IIIN
IRTC
IRTC
Operating Cash FlowLast quarter
$-701.0K
$26.2M
Free Cash FlowOCF − Capex
$-2.2M
$14.5M
FCF MarginFCF / Revenue
-1.4%
6.9%
Capex IntensityCapex / Revenue
0.9%
5.6%
Cash ConversionOCF / Net Profit
-0.09×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$439.0K
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIIN
IIIN
IRTC
IRTC
Q4 25
$-701.0K
$26.2M
Q3 25
$-17.0M
$34.9M
Q2 25
$28.5M
$27.7M
Q1 25
$-3.3M
$-7.9M
Q4 24
$19.0M
$19.2M
Q3 24
$16.2M
$24.3M
Q2 24
$18.8M
$11.8M
Q1 24
$1.4M
$-52.0M
Free Cash Flow
IIIN
IIIN
IRTC
IRTC
Q4 25
$-2.2M
$14.5M
Q3 25
$-18.7M
$20.1M
Q2 25
$26.9M
$17.3M
Q1 25
$-5.5M
$-17.3M
Q4 24
$16.3M
$12.4M
Q3 24
$14.5M
$15.5M
Q2 24
$15.5M
$3.4M
Q1 24
$-580.0K
$-61.8M
FCF Margin
IIIN
IIIN
IRTC
IRTC
Q4 25
-1.4%
6.9%
Q3 25
-10.6%
10.4%
Q2 25
15.0%
9.3%
Q1 25
-3.5%
-10.9%
Q4 24
12.6%
7.5%
Q3 24
10.8%
10.5%
Q2 24
10.7%
2.3%
Q1 24
-0.5%
-46.8%
Capex Intensity
IIIN
IIIN
IRTC
IRTC
Q4 25
0.9%
5.6%
Q3 25
1.0%
7.7%
Q2 25
0.9%
5.6%
Q1 25
1.4%
5.9%
Q4 24
2.1%
4.2%
Q3 24
1.3%
6.0%
Q2 24
2.2%
5.7%
Q1 24
1.5%
7.4%
Cash Conversion
IIIN
IIIN
IRTC
IRTC
Q4 25
-0.09×
4.70×
Q3 25
-1.17×
Q2 25
1.88×
Q1 25
-0.32×
Q4 24
17.56×
Q3 24
3.48×
Q2 24
2.86×
Q1 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IIIN
IIIN

Welded Wire Reinforcement$108.4M68%
PC Strand$51.6M32%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons